RxDoctor Payments Data

Wesley Merritt, MD

Anesthesiology · Allen, TXNPI 1396700571

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Medtronic at 32.7% of the total. Reporting peaked in 2020 at $689 and has fallen 91.4% since, to $59 in 2024. Among anesthesiology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,862in general payments, 2019–2025

Across 110 payments — averaging $16.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$609
  • Arbor Pharmaceuticals, Inc.$454
  • AbbVie$128
  • Boston Scientific$112
  • Azurity Pharmaceuticals, Inc.$69
  • Biohaven Pharmaceuticals, Inc.$69
  • plus $421 from 15 others
$345in research payments, 2019–2025

Across 1 payment — averaging $345.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$345

What the payments were for

  • Food & beverage$1,862100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,862 in reported general payments places this provider in the 90th percentile of 3,899 anesthesiology providers in Texas.

See all anesthesiology providers in Texas →

Medicare billing

Part B allowed, 2024
$63,849
Medicare patients
239
Services billed
713

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Piroxicam14$7,980
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen119$4,624
Calcipotriene13$3,747
Amitriptyline Hcl82$2,832
Gabapentin95$2,462
Methadone Hcl111$1,587
Methocarbamol57$1,498
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen62$1,476
Baclofen24$1,280
Pregabalin22$909
Morphine Sulfate ErMorphine Sulfate36$865
Tramadol Hcl51$825
Diclofenac Sodium28$767
Oxycodone Hcl41$746
Tizanidine Hcl46$662

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Allen

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →